Cargando…
In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
BACKGROUND: Deoxyhypusine synthase (DHS) catalyzes the first step in hypusine biosynthesis of eukaryotic initiation factor 5A (eIF-5A) in Plasmodium falciparum. Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438091/ https://www.ncbi.nlm.nih.gov/pubmed/22694849 http://dx.doi.org/10.1186/1471-2180-12-107 |
_version_ | 1782242865279139840 |
---|---|
author | Schwentke, Andreas Krepstakies, Marcel Mueller, Ann-Kristin Hammerschmidt-Kamper, Christiane Motaal, Basma A Bernhard, Tina Hauber, Joachim Kaiser, Annette |
author_facet | Schwentke, Andreas Krepstakies, Marcel Mueller, Ann-Kristin Hammerschmidt-Kamper, Christiane Motaal, Basma A Bernhard, Tina Hauber, Joachim Kaiser, Annette |
author_sort | Schwentke, Andreas |
collection | PubMed |
description | BACKGROUND: Deoxyhypusine synthase (DHS) catalyzes the first step in hypusine biosynthesis of eukaryotic initiation factor 5A (eIF-5A) in Plasmodium falciparum. Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease. CNI-1493 prevented infected mice from experimental cerebral malaria by decreasing the levels in hypusinated eIF-5A and serum TNF, implicating a link between cytokine signaling and the hypusine pathway. Therefore we addressed the question whether either DHS itself or eIF-5A is required for the outcome of severe malaria. In a first set of experiments we performed an in vitro knockdown of the plasmodial eIF-5A and DHS proteins by RNA interference (RNAi) in 293 T cells. Secondly, transfection of siRNA constructs into murine Plasmodium schizonts was performed which, in turn, were used for infection. RESULTS: 293 T cells treated with plasmodial DHS- and eIF-5A specific siRNAs or control siRNAs were analyzed by RT-PCR to determine endogenous dhs -and eIF-5A mRNA levels. The expressed DHS-shRNA and EIF-5A-shRNA clearly downregulated the corresponding transcript in these cells. Interestingly, mice infected with transgenic schizonts expressing either the eIF-5A or dhs shRNA showed an elevated parasitemia within the first two days post infection which then decreased intermittently. These results were obtained without drug selection. Blood samples, which were taken from the infected mice at day 5 post infection with either the expressed EIF-5A-shRNA or the DHS-shRNA were analyzed by RT-PCR and Western blot techniques, demonstrating the absence of either the hypusinated form of eIF-5A or DHS. CONCLUSIONS: Infection of NMRI mice with schizonts from the lethal P. berghei ANKA wildtype strain transgenic for plasmodial eIF-5A-specific shRNA or DHS-specific shRNA resulted in low parasitemia 2–9 days post infection before animals succumbed to hyperparasitemia similar to infections with the related but non-lethal phenotype P. berghei strain NK65. RT-PCR and Western blot experiments performed with blood from the transfected erythrocytic stages showed that both genes are important for the proliferation of the parasite. Moreover, these experiments clearly demonstrate that the hypusine pathway in Plasmodium is linked to human iNos induction. |
format | Online Article Text |
id | pubmed-3438091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34380912012-09-11 In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway Schwentke, Andreas Krepstakies, Marcel Mueller, Ann-Kristin Hammerschmidt-Kamper, Christiane Motaal, Basma A Bernhard, Tina Hauber, Joachim Kaiser, Annette BMC Microbiol Research Article BACKGROUND: Deoxyhypusine synthase (DHS) catalyzes the first step in hypusine biosynthesis of eukaryotic initiation factor 5A (eIF-5A) in Plasmodium falciparum. Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease. CNI-1493 prevented infected mice from experimental cerebral malaria by decreasing the levels in hypusinated eIF-5A and serum TNF, implicating a link between cytokine signaling and the hypusine pathway. Therefore we addressed the question whether either DHS itself or eIF-5A is required for the outcome of severe malaria. In a first set of experiments we performed an in vitro knockdown of the plasmodial eIF-5A and DHS proteins by RNA interference (RNAi) in 293 T cells. Secondly, transfection of siRNA constructs into murine Plasmodium schizonts was performed which, in turn, were used for infection. RESULTS: 293 T cells treated with plasmodial DHS- and eIF-5A specific siRNAs or control siRNAs were analyzed by RT-PCR to determine endogenous dhs -and eIF-5A mRNA levels. The expressed DHS-shRNA and EIF-5A-shRNA clearly downregulated the corresponding transcript in these cells. Interestingly, mice infected with transgenic schizonts expressing either the eIF-5A or dhs shRNA showed an elevated parasitemia within the first two days post infection which then decreased intermittently. These results were obtained without drug selection. Blood samples, which were taken from the infected mice at day 5 post infection with either the expressed EIF-5A-shRNA or the DHS-shRNA were analyzed by RT-PCR and Western blot techniques, demonstrating the absence of either the hypusinated form of eIF-5A or DHS. CONCLUSIONS: Infection of NMRI mice with schizonts from the lethal P. berghei ANKA wildtype strain transgenic for plasmodial eIF-5A-specific shRNA or DHS-specific shRNA resulted in low parasitemia 2–9 days post infection before animals succumbed to hyperparasitemia similar to infections with the related but non-lethal phenotype P. berghei strain NK65. RT-PCR and Western blot experiments performed with blood from the transfected erythrocytic stages showed that both genes are important for the proliferation of the parasite. Moreover, these experiments clearly demonstrate that the hypusine pathway in Plasmodium is linked to human iNos induction. BioMed Central 2012-06-13 /pmc/articles/PMC3438091/ /pubmed/22694849 http://dx.doi.org/10.1186/1471-2180-12-107 Text en Copyright ©2012 Schwentke et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Schwentke, Andreas Krepstakies, Marcel Mueller, Ann-Kristin Hammerschmidt-Kamper, Christiane Motaal, Basma A Bernhard, Tina Hauber, Joachim Kaiser, Annette In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
title | In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
title_full | In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
title_fullStr | In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
title_full_unstemmed | In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
title_short | In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
title_sort | in vitro and in vivo silencing of plasmodial dhs and eif-5a genes in a putative, non-canonical rnai-related pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438091/ https://www.ncbi.nlm.nih.gov/pubmed/22694849 http://dx.doi.org/10.1186/1471-2180-12-107 |
work_keys_str_mv | AT schwentkeandreas invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT krepstakiesmarcel invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT muellerannkristin invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT hammerschmidtkamperchristiane invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT motaalbasmaa invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT bernhardtina invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT hauberjoachim invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway AT kaiserannette invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway |